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Na+-dependent amino isobutyric acid transport by two ncurobla~toma cell lines with and without amplification of the oneogene N.mye is studied. 
Surprisingly, the corttribution o~ system A is £~reater in the cell line showing ac 2~-mj,c amp~il'tcation. Preliminary data support a role ~or essential 
tyrosine and cy~teine residues in the active center of the carriers, mainly in system A. 
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1. INTRODUCTION 
Cells need to continuously exchange matter, energy, 
and information to maintain the characteristic negen- 
tropy of life ill. The flow of amino acids through the 
plasma membrane of eukaryotic cells is driven mainly 
by carrier proteins. The incorporation of amino acids 
against a concentration gradient is usually cottpied to 
a favourable Na ÷ gradient, which acts as the driving 
systems first described and, indeed, the most conspictt- 
ous ones in very different types of eukaryotic cells are 
the so-called systems A and ASC [3,4]. The expression 
of system A is usually repressed in normal cells, but it 
is highly enhanced in neoplastic or proliferant cells [5]. 
lr~ the present reporL "N~-dependent transport o~ 
amino acids by neuroblastoma ceils is studied by using 
the analog amino isobutyric acid (A1B). The actual con- 
tribution of both systems A and ASC has been investi- 
gat©6 ~n "two neuro'~Sas~oma ce'~5 55n~s w'ffn fi]~erem ex- 
2. IV[ATER.I:AL,~ AND M:ETHODS 
2.1. Materials 
Culture dishes were from Falcon (Onnard, CA, USA). Twelve-well 
tissue-eullure cluster dishes were from Co,tar (Ca~brid~.g~ MA~ 
from Gibeo (Eggenstein, Germany). 2-Amino[1J'~Clhobutyric acid 
(1.85 G .~x~.~ m~.~ f~x~ ~.~9~.~.~ ~, 'e~,~rA2, ,  C .~)~ 
Eeolume liquid ~eintillation counting solution was supplied by ICiN 
(Meekenheim, Germany). All other reagents were IYOln Sisma (Dei- 
senhofen, Germany), 
2.2. Neurobla~'toma cell lines 
Two wdl-e~tablished cell lines were used: SH-EP (a homogeneous 
SK-N-SH-derived subline), and IMR-32, which carry i, and 25 copies 
Correspondence address: M.A. Medina, lin Neuenheimer Feld 326, 
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of N-rove oncogene, respectively. Cell culture conditions have been 
described elsewhere [6]. 
2.3. Transport in cuhure cells 
The celh used for transport experiments were seeded into twelve- 
well cluster dishes and they were used when confluent. The buffered 
medimn u~ed in the transport was !37 mM NaCI, 5.4 mM KCI, 2.8 
mM CaCI,, 1.2 mM MsSO,~, 10 mM HEPES adjusted to pH 7.4 with 
Tri~. Cetl~ ~ere ~a~txed tr~ tl~L~ raed[artx artd tr~m~pert ~ [att[~e~ b2/ 
pCi/ml of the labelled amino acid) at room temperature (20°C). The 
ing with 3 × 1 ml aliquots of ice-cold 137 mM NaCI, 10 mM Tris- 
HEPES, pH 7.4. Plates were drained and 0.3 ml 0.5% Triton X-100 
added, cells were then removed with a cell scraper and resu.~pended 
in this medium. 250-#1 saznplcs were diasolved in 5 ml scintillation 
solution for counting and protein was determin~,J using the method 
of Bradford [7]. Na'-independent uptake was perlbrmcd using 137 
fn tile expenhaents designed to fdentd~ essential' ~roups, cel'fs were 
preincubated for 1 h in the presence of 0.17 mM 7-ehloro.4-ni- 
trobenzo-2-oxa-l.3-diazole (NBD-CI), for 15 rain in the pre~ence of 
0.5 mM para-chlorobenzenesulfonate (PCMI]S), or for 2 rain in the 
3. RESULTS AND DISCUSSION 
~. L AI,~ ,',~m~p't,'~,~, ~ ~* ,',~,'~'~.~',',~,~" ,~mg l,i','e'~r 
Pioneer work by Christensen led years ago to the 
proposition that abnormally strong amino acid accu- 
creasea" accummhtibn couih" de aedl~vetP el[lier ~y tin- 
creased affinities and capacities of the transport sys- 
tems, and/or by enhanced expression of system Ao usu- 
ally repressed in normal non-proliferant cells [5]. 
Neuroblastoma cell lines carrying diffe.L'ent numbers 
of copy for the N-myc oncogene have been established. 
The N-myc oncogene is frequently amplified in ad- 
vanced stages, but not in initial stages of human neuro- 
blastoma [9], and N-myc amplification (with corre- 
spondingly enhanced N-myc expression) correlates with 
clinical outcome [I0]. This fact makes neuroblastoma 
20 Published by Elsevier Science Publishers B.V. 
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FiB. I. Time course ol" AIB uptake by SH-EP cells. Transport expgri- 
mints were carried out in NaCI buffer without (@) and with 5 mM 
threonine added (~), as well as in choline chloride buffer (o), as 
described in s~,~tion 2. Total Na+-dependent AIB transport is also 
delatcted (~,  R.epresentatNe r sults are shown, 
0"- 
Time (rain) 
Fi B. 2. Time course of AIB uptake by IMR-32 eel|s. Transport exper- 
iments were carried out in NaCI buffer (e), as well as in choline 
chloride buffer (o}, as described in section 2, Total Na*-dependent 
AIB transport is also de/;i¢led I'~). RepreSeulative r sults are shown. 
amino acid uptake related to cell proliferation. 
We examined plasma membrane transport of the non 
metabolizable amino acid AIB in two established 
human neuroblastoma cell lines, which differ in their 
degree of N-t~O~c amplification and consequent N.myc 
express'ton: ~H-E'P harbors one° an6 ~Mi~,.'52 ~'~en't~- 
five copies of N-myc. Figs. 1 and 2 show the time course 
of AIB transport into SH-EP and IMR-32 cells, respec- 
tively. It is noteworthy that both Na*-dependent and 
}M:R-32 ce))s. TS~ eaper~r~ema~ re~h~ 5a -,v~B ~ilb 
the expected behaviour of cells during neoplastic trans- 
paragraph of  this ~cdon. 
Tal~t~ I 
l~li|tSit'ory etl-eet ol ~orne am~ho ae~ on ~h :ca~pentd:m ~¢lWup~a~c- 
by SH-EP cells 
Amino acid (5 raM) AIB uptake (%) 
None 100 ± I 
Glutamine 20 __. 5 
Leacine 81 ± 14 
Lysine 80 _ 5 
Phenylalanine 80 _+ 10 
Threonine 77 "2_ 17 
Methyl-AIB 22 _'L- 5 
A~sa),s were carried out as described in section 2. Figures are means 
+ S.D. for three different determinations. 
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Since Na*-dependent AIB transport by both neuro- 
&~a~t~¢~8. cell fiae~ was linear with time at leas~ for the 
first 5 minutes (see Figs. l and 2), the rest of the exper- 
imental work was carried out at this fixed time. 
To examine the relative contribution of systems A 
and ASC to the total Na+-dependent AIB transport by 
neuroblastoma cells, we used methyl-AIB, a specific 
haves as a specific inhibitor for system ASC in some cell 
types [12]. Tables 1 and 11 show surprising and unex- 
pected results. The effect ofmethyl-AIB shows that sys- 
IMR-32 cells, system A accounted for less than 50% of 
total Na*-dependent AIB transport (Table II). Thus, 
petted, the contribution of system A to transport is 
greater in SH-EP cells, corresponding to the initial 
Table II 
Effects of methyl-AIB and threonine on Na*-dependent tran5port of  
A1B by IMR-32 cells 
Amino acid (5 mM) AIB uptake (%) 
None I00 -.t. 5 
Methyl-AlB 53 +_ 6 
Threonine 30 + 1 
Mcthyl-AIB + threoai~e 0 
Assays were carried oat as dc~ribed in section 2. Figures are means 
_+ S.D. for three different determinations. 
21 
s t~ ~ ,~',~,9,,~a~s,*~er, e.  k;',vd' ~ ~,~o c,.'~'ag,ee'eo~ 
has been described for system ASC and, therefore, the 
actual causes of this unexpected behaviour should be 
investigated. On the other hand, threonine behaved as 
a specific inhibitor for system ASC in SH-EP cells but 
not in IMR.32 cells, in which threonine not only inhib- 
it~eb "transport ~ system ~ ~m ahso ~zrtmh3.v 3n'fi)~o- 
Rug <,~,v,~i~ 6"~ ~')~w, ~ ~'q~% ~.  
3.2. Ft~rther oreliminaLv cfiaracte¢izatiott of total Na +- 
dependent AIB transport by SH-EP ceils 
Table I shows the amino acid specificity of Na+-de - 
greatest inhibition was produced by glutamine, a well- 
characterized substrate for Na+-dependent transport 
systems. The slight inhibitions by leucine and phenyl- 
alanine were also expected, since both amino acids are 
mainly transported via system L [5]. It is noteworthy 
that there was a slight but significant inhibition by the 
cationic amino acid lysine. 
In order to detect specific amino acid residues in the 
p(ount~s ar~ avff im~. ~F or )~0slanre, ~)ge p~re.se~0ce oJ' .~- 
sential sul~ydryl groups can be detected by using 
PCMBS [13], essential arginine residues can be detected 
with phenylglyoxaI [14], and essential tyrosine residues 
these three inhibitors in a series of preliminary experi- 
ments. The pretreatment with phenyl~yoxa/seemed ~o 
permeabilize SH-EP cells, as shown by high increases in 
without exogenously added sodium ions (results not 
shown). NBD-CI seemed to be toxic for SH-EP cells, 
since pretreatment with NBD-CI produced a 36% de- 
crease in final total protein; normalization of data with 
ta',~ ~t~S. {e'~e, gtn- ,~"e ¢?ro'~lr~'. Fi~:ra??y; a ~rarr. t'e'n'rr pre- 
treatment with PCMBS seemed to be inocuous to SH- 
EP cells and did not alter the levels of lX/a+-independent 
AIB transporL but it inhibited transport by system A 
(82% inhibition) and, to a lesser extent, transport by 
system ASC (65% inhibition). 
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